<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00583908</url>
  </required_header>
  <id_info>
    <org_study_id>CR-0710 pt 3</org_study_id>
    <secondary_id>ETOR-507(under GNR-011)</secondary_id>
    <nct_id>NCT00583908</nct_id>
  </id_info>
  <brief_title>Evaluation of Orientation and Visual Acuity of Four Toric Soft Contact Lenses When Head is Tilted at 90 Degrees</brief_title>
  <official_title>Clinical and Theoretical Evaluation of Factors Affecting Soft Toric Lens Performance: Part 3</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Visioncare Research Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the relative performance of a new toric soft
      contact lens against three toric contact lens currently available in market, specifically
      with orientation and visual acuity when head is tilted at 90 degrees.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Non-dispensing single-masked (subject-masked), randomised, 1-visit controlled study, ~2 hour
      duration.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">January 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lens Orientation During Head Tilt.</measure>
    <time_frame>after fit of each of the four lens insertions</time_frame>
    <description>Degree of lens rotation on the eye with the head tilted.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Acuity During Head Tilt</measure>
    <time_frame>after each of the four lens insertions</time_frame>
    <description>logarithm of the minimum angle of resolution (logMar) ideal is 0.0 and represents 20/20 Snellen acuity.
logMar values &gt; 0.00 indicate vision poorer than the ideal and values &lt;0.00 indicate vision greater than the ideal.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Degree of Lens Rotation in Superior Gaze.</measure>
    <time_frame>After each of the four lens insertions</time_frame>
    <description>Degree of lens rotation while participant is gazing up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of Lens Rotation in Superior-temporal Gaze.</measure>
    <time_frame>After each of 4 lens insertions.,</time_frame>
    <description>Degree of lens rotation while participant is gazing up and out(towards the temple).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of Lens Rotation in Superior-nasal Gaze.</measure>
    <time_frame>After each of the four lens insertions</time_frame>
    <description>Degree of lens rotation while participant is gazing up and in(towards the nose).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of Lens Rotation in Temporal Gaze.</measure>
    <time_frame>After each of the four lens insertions</time_frame>
    <description>Degree of lens rotation while participant is gazing out(towards the temple).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of Lens Rotation in Nasal Gaze.</measure>
    <time_frame>After each of the four lens insertions</time_frame>
    <description>Degree of lens rotation while participant is gazing in(towards the nose).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of Lens Rotation Inferior-temporal Gaze.</measure>
    <time_frame>After each of the four lens insertions</time_frame>
    <description>Degree of lens rotation while participant is gazing down and out.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of Lens Rotation in Inferior-nasal Gaze.</measure>
    <time_frame>After each of the four lens insertions</time_frame>
    <description>Degree of lens rotation while participant is gazing down and in.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of Lens Rotation in Inferior Gaze.</measure>
    <time_frame>After each of the four lens insertions</time_frame>
    <description>Degree of lens rotation while participant is gazing down.</description>
  </secondary_outcome>
  <number_of_arms>12</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>Group 1: lotrafilcon B/senofilcon A/balafilcon A/omafilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. Period 1: lotrafilcon B /period 2: senofilcon A / period 3: balafilcon A / period 4: omafilcon A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2 lotrafilcon B/omafilcon A/senofilcon A/balafilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: lotrafilcon B / period 2: omafilcon A / period 3: senofilcon A / period 4: balafilcon A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3 lotrafilcon B/balafilcon A/senofilcon A/omafilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: lotrafilcon B / period 2: balafilcon A / period 3: senofilcon A / period 4: omafilcon A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4 senofilcon A/lotrafilcon B/omafilcon A/balafilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: lotrafilcon B / period 3: omafilcon A / period 4: balafilcon A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 5 senofilcon A/omafilcon A/balafilcon A/lotrafilcon B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: omafilcon A / period 3: balafilcon A / period 4: lotrafilcon B</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 6 senofilcon A/balafilcon A/lotrafilcon B/omafilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: balafilcon A / period 3: lotrafilcon B / period 4: omafilcon A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 7 omafilcon B/lotrafilcon B/senofilcon A/balafilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: omafilcon A / period 2: lotrafilcon B / period 3: senofilcon A / period 4: balafilcon A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 8 balafilcon A/lotrafilcon B/senofilcon A/omafilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: lotrafilcon B / period 3: senofilcon A / period 4: omafilcon A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 9 balafilcon A/lotrafilcon B/omafilcon A/senofilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: lotrafilcon B / period 3: omafilcon A / period 4: senofilcon A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 10 balafilcon A/senofilcon A/lotrafilcon B/omafilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: senofilcon A / period 3: lotrafilcon B / period 4: omafilcon A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 11 balafilcon A/senofilcon A/omafilcon A//lotrafilcon B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: senofilcon A / period 3: omafilcon A / period 4: lotrafilcon B</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 12 balafilcon A/omafilcon A/lotrafilcon B/senofilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: omafilcon A / period 3: lotrafilcon B / period 4: senofilcon A</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>senofilcon A</intervention_name>
    <description>toric contact lens</description>
    <arm_group_label>Group 1: lotrafilcon B/senofilcon A/balafilcon A/omafilcon A</arm_group_label>
    <arm_group_label>Group 2 lotrafilcon B/omafilcon A/senofilcon A/balafilcon A</arm_group_label>
    <arm_group_label>Group 3 lotrafilcon B/balafilcon A/senofilcon A/omafilcon A</arm_group_label>
    <arm_group_label>Group 4 senofilcon A/lotrafilcon B/omafilcon A/balafilcon A</arm_group_label>
    <arm_group_label>Group 5 senofilcon A/omafilcon A/balafilcon A/lotrafilcon B</arm_group_label>
    <arm_group_label>Group 6 senofilcon A/balafilcon A/lotrafilcon B/omafilcon A</arm_group_label>
    <arm_group_label>Group 7 omafilcon B/lotrafilcon B/senofilcon A/balafilcon A</arm_group_label>
    <arm_group_label>Group 8 balafilcon A/lotrafilcon B/senofilcon A/omafilcon A</arm_group_label>
    <arm_group_label>Group 9 balafilcon A/lotrafilcon B/omafilcon A/senofilcon A</arm_group_label>
    <arm_group_label>Group 10 balafilcon A/senofilcon A/lotrafilcon B/omafilcon A</arm_group_label>
    <arm_group_label>Group 11 balafilcon A/senofilcon A/omafilcon A//lotrafilcon B</arm_group_label>
    <arm_group_label>Group 12 balafilcon A/omafilcon A/lotrafilcon B/senofilcon A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>balafilcon A toric</intervention_name>
    <description>toric contact lens</description>
    <arm_group_label>Group 1: lotrafilcon B/senofilcon A/balafilcon A/omafilcon A</arm_group_label>
    <arm_group_label>Group 2 lotrafilcon B/omafilcon A/senofilcon A/balafilcon A</arm_group_label>
    <arm_group_label>Group 3 lotrafilcon B/balafilcon A/senofilcon A/omafilcon A</arm_group_label>
    <arm_group_label>Group 4 senofilcon A/lotrafilcon B/omafilcon A/balafilcon A</arm_group_label>
    <arm_group_label>Group 5 senofilcon A/omafilcon A/balafilcon A/lotrafilcon B</arm_group_label>
    <arm_group_label>Group 6 senofilcon A/balafilcon A/lotrafilcon B/omafilcon A</arm_group_label>
    <arm_group_label>Group 7 omafilcon B/lotrafilcon B/senofilcon A/balafilcon A</arm_group_label>
    <arm_group_label>Group 8 balafilcon A/lotrafilcon B/senofilcon A/omafilcon A</arm_group_label>
    <arm_group_label>Group 9 balafilcon A/lotrafilcon B/omafilcon A/senofilcon A</arm_group_label>
    <arm_group_label>Group 10 balafilcon A/senofilcon A/lotrafilcon B/omafilcon A</arm_group_label>
    <arm_group_label>Group 11 balafilcon A/senofilcon A/omafilcon A//lotrafilcon B</arm_group_label>
    <arm_group_label>Group 12 balafilcon A/omafilcon A/lotrafilcon B/senofilcon A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>lotrafilcon B toric</intervention_name>
    <description>toric contact lens</description>
    <arm_group_label>Group 1: lotrafilcon B/senofilcon A/balafilcon A/omafilcon A</arm_group_label>
    <arm_group_label>Group 2 lotrafilcon B/omafilcon A/senofilcon A/balafilcon A</arm_group_label>
    <arm_group_label>Group 3 lotrafilcon B/balafilcon A/senofilcon A/omafilcon A</arm_group_label>
    <arm_group_label>Group 4 senofilcon A/lotrafilcon B/omafilcon A/balafilcon A</arm_group_label>
    <arm_group_label>Group 5 senofilcon A/omafilcon A/balafilcon A/lotrafilcon B</arm_group_label>
    <arm_group_label>Group 6 senofilcon A/balafilcon A/lotrafilcon B/omafilcon A</arm_group_label>
    <arm_group_label>Group 7 omafilcon B/lotrafilcon B/senofilcon A/balafilcon A</arm_group_label>
    <arm_group_label>Group 8 balafilcon A/lotrafilcon B/senofilcon A/omafilcon A</arm_group_label>
    <arm_group_label>Group 9 balafilcon A/lotrafilcon B/omafilcon A/senofilcon A</arm_group_label>
    <arm_group_label>Group 10 balafilcon A/senofilcon A/lotrafilcon B/omafilcon A</arm_group_label>
    <arm_group_label>Group 11 balafilcon A/senofilcon A/omafilcon A//lotrafilcon B</arm_group_label>
    <arm_group_label>Group 12 balafilcon A/omafilcon A/lotrafilcon B/senofilcon A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>omafilcon A</intervention_name>
    <description>toric contact lens</description>
    <arm_group_label>Group 1: lotrafilcon B/senofilcon A/balafilcon A/omafilcon A</arm_group_label>
    <arm_group_label>Group 2 lotrafilcon B/omafilcon A/senofilcon A/balafilcon A</arm_group_label>
    <arm_group_label>Group 3 lotrafilcon B/balafilcon A/senofilcon A/omafilcon A</arm_group_label>
    <arm_group_label>Group 4 senofilcon A/lotrafilcon B/omafilcon A/balafilcon A</arm_group_label>
    <arm_group_label>Group 5 senofilcon A/omafilcon A/balafilcon A/lotrafilcon B</arm_group_label>
    <arm_group_label>Group 6 senofilcon A/balafilcon A/lotrafilcon B/omafilcon A</arm_group_label>
    <arm_group_label>Group 7 omafilcon B/lotrafilcon B/senofilcon A/balafilcon A</arm_group_label>
    <arm_group_label>Group 8 balafilcon A/lotrafilcon B/senofilcon A/omafilcon A</arm_group_label>
    <arm_group_label>Group 9 balafilcon A/lotrafilcon B/omafilcon A/senofilcon A</arm_group_label>
    <arm_group_label>Group 10 balafilcon A/senofilcon A/lotrafilcon B/omafilcon A</arm_group_label>
    <arm_group_label>Group 11 balafilcon A/senofilcon A/omafilcon A//lotrafilcon B</arm_group_label>
    <arm_group_label>Group 12 balafilcon A/omafilcon A/lotrafilcon B/senofilcon A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. be at least 18 and less than or equal to 50 years of age

          2. be able and willing to adhere to the instructions set forth in the protocol.

          3. have a distance spherical component between -1.00 D and -6.00D with cylinder in the
             range of 0.75 D to 1.75D

          4. Sign the STATEMENT OF INFORMED CONSENT.

          5. Have normal, healthy eyes

        Exclusion Criteria:

          1. The presence of ocular or systemic disease or need for medication which might
             interfere with contact lens wear.

          2. Pre-existing ocular disease precluding contact lens fitting.

          3. Insufficient lacrimal secretions

          4. Aphakia, keratoconus or a highly irregular cornea

          5. Previous eye surgery involving the anterior segment

          6. Current pregnancy or lactation (to the best of the subject's knowledge).

          7. Use of concurrent ocular medication

          8. Active participation in another clinical study at any time during this study.-
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Graeme Young, BSc, MPhil</last_name>
    <role>Principal Investigator</role>
    <affiliation>Visioncare Research Ltd.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Visioncare Research Ltd.</name>
      <address>
        <city>Farnham</city>
        <zip>GU9 7EN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2007</study_first_submitted>
  <study_first_submitted_qc>December 31, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 2, 2008</study_first_posted>
  <results_first_submitted>August 18, 2009</results_first_submitted>
  <results_first_submitted_qc>August 18, 2009</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 28, 2009</results_first_posted>
  <last_update_submitted>May 5, 2015</last_update_submitted>
  <last_update_submitted_qc>May 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>astigmatism</keyword>
  <keyword>orientation</keyword>
  <keyword>visual acuity</keyword>
  <keyword>contact lenses</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Lotrafilcon B / Senofilcon A / Balafilcon A / Omafilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="P2">
          <title>Lotrafilcon B / Omafilcon A / Senofilcon A / Balafilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="P3">
          <title>Lotrafilcon B / Balafilcon A / Senofilcon A / Omafilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="P4">
          <title>Senofilcon A / Lotrafilcon B / Omafilcon A / Balafilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="P5">
          <title>Senofilcon A / Omafilcon A / Balafilcon A / Lotrafilcon B</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="P6">
          <title>Senofilcon A / Balafilcon A / Lotrafilcon B / Omafilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="P7">
          <title>Omafilcon A / Lotrafilcon B / Senofilcon A / Balafilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="P8">
          <title>Balafilcon A / Lotrafilcon B / Senofilcon A / Omafilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="P9">
          <title>Balafilcon A / Lotrafilcon B / Omafilcon A / Senofilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="P10">
          <title>Balafilcon A / Senofilcon A / Lotrafilcon B / Omafilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="P11">
          <title>Balafilcon A / Senofilcon A / Omafilcon A / Lotrafilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="P12">
          <title>Balafilcon A / Omafilcon A / Lotrafilcon B / Senofilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Period 1 - First Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Period 2 - Second Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Period 3 - Third Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Period 4 - Fourth Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Overall Study Population</title>
          <description>Summary for overall study population</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="14"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42.1" spread="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Lens Orientation During Head Tilt.</title>
        <description>Degree of lens rotation on the eye with the head tilted.</description>
        <time_frame>after fit of each of the four lens insertions</time_frame>
        <population>Only participants who completed the study per protocol. Some participants had missing data for some lenses.</population>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A Toric</title>
            <description>senofilcon A toric worn in either the first, second, third or fourth periods.</description>
          </group>
          <group group_id="O2">
            <title>Balafilcon A Toric</title>
            <description>balafilcon A toric worn in either the first, second, third or fourth periods</description>
          </group>
          <group group_id="O3">
            <title>Lotrafilcon B Toric</title>
            <description>lotrafilcon B toric worn in either the first, second, third, or fourth periods.</description>
          </group>
          <group group_id="O4">
            <title>Omafilcon A Toric</title>
            <description>omafilcon A toric worn in either the first, second, third, or fourth periods.</description>
          </group>
        </group_list>
        <measure>
          <title>Lens Orientation During Head Tilt.</title>
          <description>Degree of lens rotation on the eye with the head tilted.</description>
          <population>Only participants who completed the study per protocol. Some participants had missing data for some lenses.</population>
          <units>Degree of rotation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="13"/>
                <count group_id="O4" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.2" spread="10.7"/>
                    <measurement group_id="O2" value="39.7" spread="18.5"/>
                    <measurement group_id="O3" value="27.6" spread="22.7"/>
                    <measurement group_id="O4" value="39.3" spread="15.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative Hypothesis was senofilcon A toric was superior to balafilcon A toric by having less degrees of rotation</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Paired t-test</p_value_desc>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-27.5</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>17.1</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>mean difference was senofilcon A minus balafilcon A</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Hypothesis was senofilcon A toric was superior to lotrafilcon B toric by having less degree of rotation</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0002</p_value>
            <p_value_desc>paired t-test</p_value_desc>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-15.4</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>17.8</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>mean difference is senofilcon A minus lotrafilcon B</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Hypothesis was senofilcon A toric was superior to omafilcon A toric by having less degree of rotation</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>paired t-test</p_value_desc>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-27.0</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>12.4</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus omafilcon A</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity During Head Tilt</title>
        <description>logarithm of the minimum angle of resolution (logMar) ideal is 0.0 and represents 20/20 Snellen acuity.
logMar values &gt; 0.00 indicate vision poorer than the ideal and values &lt;0.00 indicate vision greater than the ideal.</description>
        <time_frame>after each of the four lens insertions</time_frame>
        <population>Only participants who completed the study per protocol. Some participants had missing data for some of the lenses.</population>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A Toric</title>
            <description>senofilcon A toric worn in either the first, second, third or fourth periods.</description>
          </group>
          <group group_id="O2">
            <title>Balafilcon A Toric</title>
            <description>balafilcon A toric worn in either the first, second, third or fourth periods</description>
          </group>
          <group group_id="O3">
            <title>Lotrafilcon B Toric</title>
            <description>lotrafilcon B toric worn in either the first, second, third, or fourth periods.</description>
          </group>
          <group group_id="O4">
            <title>Omafilcon A Toric</title>
            <description>omafilcon A toric worn in either the first, second, third, or fourth periods.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity During Head Tilt</title>
          <description>logarithm of the minimum angle of resolution (logMar) ideal is 0.0 and represents 20/20 Snellen acuity.
logMar values &gt; 0.00 indicate vision poorer than the ideal and values &lt;0.00 indicate vision greater than the ideal.</description>
          <population>Only participants who completed the study per protocol. Some participants had missing data for some of the lenses.</population>
          <units>logMAR units</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="13"/>
                <count group_id="O4" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.06"/>
                    <measurement group_id="O2" value="0.15" spread="0.20"/>
                    <measurement group_id="O3" value="0.07" spread="0.10"/>
                    <measurement group_id="O4" value="0.11" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis was senofilcon A toric was superior to balafilcon A toric by having a lower logMAR score</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0083</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.13</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.15</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference was senofilcon A minus balafilcon A</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis was senofilcon A toric was superior to lotrafilcon B toric by having a lower logMAR score</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.052</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.06</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.09</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference was senofilcon A minus lotrafilcon B</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis was senofilcon A toric was superior to omafilcon A toric by having a lower logMAR score</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.015</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.13</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.14</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference was senofilcon A minus omafilcon A</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Degree of Lens Rotation in Superior Gaze.</title>
        <description>Degree of lens rotation while participant is gazing up.</description>
        <time_frame>After each of the four lens insertions</time_frame>
        <population>Only participants who completed the study per protocol. Some participants had missing data for some lenses.</population>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A Toric</title>
            <description>senofilcon A toric worn in either the first, second, third or fourth periods.</description>
          </group>
          <group group_id="O2">
            <title>Balafilcon A Toric</title>
            <description>balafilcon A toric worn in either the first, second, third or fourth periods</description>
          </group>
          <group group_id="O3">
            <title>Lotrafilcon B Toric</title>
            <description>lotrafilcon B toric worn in either the first, second, third, or fourth periods.</description>
          </group>
          <group group_id="O4">
            <title>Omafilcon A Toric</title>
            <description>omafilcon A toric worn in either the first, second, third, or fourth periods.</description>
          </group>
        </group_list>
        <measure>
          <title>Degree of Lens Rotation in Superior Gaze.</title>
          <description>Degree of lens rotation while participant is gazing up.</description>
          <population>Only participants who completed the study per protocol. Some participants had missing data for some lenses.</population>
          <units>Degree of rotation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="13"/>
                <count group_id="O4" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="3.8"/>
                    <measurement group_id="O2" value="6.0" spread="4.7"/>
                    <measurement group_id="O3" value="3.7" spread="2.6"/>
                    <measurement group_id="O4" value="6.5" spread="7.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.16</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-2.7</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>6.5</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus balafilcon A</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.73</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.3</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>3.5</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus lotrafilcon B</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.044</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-3.3</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>4.4</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference was senofilcon A minus omafilcon A</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Degree of Lens Rotation in Superior-temporal Gaze.</title>
        <description>Degree of lens rotation while participant is gazing up and out(towards the temple).</description>
        <time_frame>After each of 4 lens insertions.,</time_frame>
        <population>Only participants who completed the study per protocol. Some participants had missing data for some lenses.</population>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A Toric</title>
            <description>senofilcon A toric worn in either the first, second, third or fourth periods.</description>
          </group>
          <group group_id="O2">
            <title>Balafilcon A Toric</title>
            <description>balafilcon A toric worn in either the first, second, third or fourth periods</description>
          </group>
          <group group_id="O3">
            <title>Lotrafilcon B Toric</title>
            <description>lotrafilcon B toric worn in either the first, second, third, or fourth periods.</description>
          </group>
          <group group_id="O4">
            <title>Omafilcon A Toric</title>
            <description>omafilcon A toric worn in either the first, second, third, or fourth periods.</description>
          </group>
        </group_list>
        <measure>
          <title>Degree of Lens Rotation in Superior-temporal Gaze.</title>
          <description>Degree of lens rotation while participant is gazing up and out(towards the temple).</description>
          <population>Only participants who completed the study per protocol. Some participants had missing data for some lenses.</population>
          <units>Degree of rotation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="13"/>
                <count group_id="O4" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3" spread="5.5"/>
                    <measurement group_id="O2" value="9.4" spread="5.4"/>
                    <measurement group_id="O3" value="4.9" spread="2.3"/>
                    <measurement group_id="O4" value="8.6" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.044</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>-3.1</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>5.0</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus balafilcon A</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.31</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>1.4</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>4.7</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus lotrafilcon B</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.44</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-1.5</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>5.9</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus omafilcon A</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Degree of Lens Rotation in Superior-nasal Gaze.</title>
        <description>Degree of lens rotation while participant is gazing up and in(towards the nose).</description>
        <time_frame>After each of the four lens insertions</time_frame>
        <population>Only participants who completed the study per protocol. Some participants had missing data for some lenses.</population>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A Toric</title>
            <description>senofilcon A toric worn in either the first, second, third or fourth periods.</description>
          </group>
          <group group_id="O2">
            <title>Balafilcon A Toric</title>
            <description>balafilcon A toric worn in either the first, second, third or fourth periods</description>
          </group>
          <group group_id="O3">
            <title>Lotrafilcon B Toric</title>
            <description>lotrafilcon B toric worn in either the first, second, third, or fourth periods.</description>
          </group>
          <group group_id="O4">
            <title>Omafilcon A Toric</title>
            <description>omafilcon A toric worn in either the first, second, third, or fourth periods.</description>
          </group>
        </group_list>
        <measure>
          <title>Degree of Lens Rotation in Superior-nasal Gaze.</title>
          <description>Degree of lens rotation while participant is gazing up and in(towards the nose).</description>
          <population>Only participants who completed the study per protocol. Some participants had missing data for some lenses.</population>
          <units>Degree of rotation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="13"/>
                <count group_id="O4" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.2" spread="5.4"/>
                    <measurement group_id="O2" value="5.6" spread="3.6"/>
                    <measurement group_id="O3" value="6.9" spread="4.8"/>
                    <measurement group_id="O4" value="5.8" spread="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.78</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.5</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>6.5</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus balafilcon A</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.68</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.7</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>6.3</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus lotrafilcon B</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.78</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.4</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>7.6</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus omafilcon A</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Degree of Lens Rotation in Temporal Gaze.</title>
        <description>Degree of lens rotation while participant is gazing out(towards the temple).</description>
        <time_frame>After each of the four lens insertions</time_frame>
        <population>Only participants who completed the study per protocol. Some participants had missing data for some lenses.</population>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A Toric</title>
            <description>senofilcon A toric worn in either the first, second, third or fourth periods.</description>
          </group>
          <group group_id="O2">
            <title>Balafilcon A Toric</title>
            <description>balafilcon A toric worn in either the first, second, third or fourth periods</description>
          </group>
          <group group_id="O3">
            <title>Lotrafilcon B Toric</title>
            <description>lotrafilcon B toric worn in either the first, second, third, or fourth periods.</description>
          </group>
          <group group_id="O4">
            <title>Omafilcon A Toric</title>
            <description>omafilcon A toric worn in either the first, second, third, or fourth periods.</description>
          </group>
        </group_list>
        <measure>
          <title>Degree of Lens Rotation in Temporal Gaze.</title>
          <description>Degree of lens rotation while participant is gazing out(towards the temple).</description>
          <population>Only participants who completed the study per protocol. Some participants had missing data for some lenses.</population>
          <units>Degree of rotation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="13"/>
                <count group_id="O4" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" spread="3.1"/>
                    <measurement group_id="O2" value="7.2" spread="5.8"/>
                    <measurement group_id="O3" value="2.8" spread="2.2"/>
                    <measurement group_id="O4" value="6.6" spread="5.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.11</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-3.1</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>6.5</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus balafilcon A</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.31</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>1.3</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>4.3</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus lotrafilcon B</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.16</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>-3.0</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>6.3</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus omafilcon A</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Degree of Lens Rotation in Nasal Gaze.</title>
        <description>Degree of lens rotation while participant is gazing in(towards the nose).</description>
        <time_frame>After each of the four lens insertions</time_frame>
        <population>Only participants who completed the study per protocol. Some participants had missing data for some lenses.</population>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A Toric</title>
            <description>senofilcon A toric worn in either the first, second, third or fourth periods.</description>
          </group>
          <group group_id="O2">
            <title>Balafilcon A Toric</title>
            <description>balafilcon A toric worn in either the first, second, third or fourth periods</description>
          </group>
          <group group_id="O3">
            <title>Lotrafilcon B Toric</title>
            <description>lotrafilcon B toric worn in either the first, second, third, or fourth periods.</description>
          </group>
          <group group_id="O4">
            <title>Omafilcon A Toric</title>
            <description>omafilcon A toric worn in either the first, second, third, or fourth periods.</description>
          </group>
        </group_list>
        <measure>
          <title>Degree of Lens Rotation in Nasal Gaze.</title>
          <description>Degree of lens rotation while participant is gazing in(towards the nose).</description>
          <population>Only participants who completed the study per protocol. Some participants had missing data for some lenses.</population>
          <units>Degree of rotation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="13"/>
                <count group_id="O4" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="3.3"/>
                    <measurement group_id="O2" value="7.1" spread="5.9"/>
                    <measurement group_id="O3" value="2.4" spread="1.3"/>
                    <measurement group_id="O4" value="3.3" spread="3.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.061</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-3.9</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>6.8</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus balafilcon A</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.47</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.8</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>3.9</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus lotrafilcon B</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.38</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-1.0</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>3.6</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus omafilcon A</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Degree of Lens Rotation Inferior-temporal Gaze.</title>
        <description>Degree of lens rotation while participant is gazing down and out.</description>
        <time_frame>After each of the four lens insertions</time_frame>
        <population>Only participants who completed the study per protocol. Some participants had missing data for some of the lenses.</population>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A Toric</title>
            <description>senofilcon A toric worn in either the first, second, third or fourth periods.</description>
          </group>
          <group group_id="O2">
            <title>Balafilcon A Toric</title>
            <description>balafilcon A toric worn in either the first, second, third or fourth periods</description>
          </group>
          <group group_id="O3">
            <title>Lotrafilcon B Toric</title>
            <description>lotrafilcon B toric worn in either the first, second, third, or fourth periods.</description>
          </group>
          <group group_id="O4">
            <title>Omafilcon A Toric</title>
            <description>omafilcon A toric worn in either the first, second, third, or fourth periods.</description>
          </group>
        </group_list>
        <measure>
          <title>Degree of Lens Rotation Inferior-temporal Gaze.</title>
          <description>Degree of lens rotation while participant is gazing down and out.</description>
          <population>Only participants who completed the study per protocol. Some participants had missing data for some of the lenses.</population>
          <units>Degree of rotation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="13"/>
                <count group_id="O4" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" spread="3.9"/>
                    <measurement group_id="O2" value="5.3" spread="4.1"/>
                    <measurement group_id="O3" value="3.7" spread="2.8"/>
                    <measurement group_id="O4" value="2.5" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.17</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-1.4</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>3.5</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus balafilcon A</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.89</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.2</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>5.0</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus lotrafilcon B</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.56</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>1.1</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>5.8</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus omafilcon A</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Degree of Lens Rotation in Inferior-nasal Gaze.</title>
        <description>Degree of lens rotation while participant is gazing down and in.</description>
        <time_frame>After each of the four lens insertions</time_frame>
        <population>Only participants who completed the study per protocol. Some participants had missing data for some of the lenses.</population>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A Toric</title>
            <description>senofilcon A toric worn in either the first, second, third or fourth periods.</description>
          </group>
          <group group_id="O2">
            <title>Balafilcon A Toric</title>
            <description>balafilcon A toric worn in either the first, second, third or fourth periods</description>
          </group>
          <group group_id="O3">
            <title>Lotrafilcon B Toric</title>
            <description>lotrafilcon B toric worn in either the first, second, third, or fourth periods.</description>
          </group>
          <group group_id="O4">
            <title>Omafilcon A Toric</title>
            <description>omafilcon A toric worn in either the first, second, third, or fourth periods.</description>
          </group>
        </group_list>
        <measure>
          <title>Degree of Lens Rotation in Inferior-nasal Gaze.</title>
          <description>Degree of lens rotation while participant is gazing down and in.</description>
          <population>Only participants who completed the study per protocol. Some participants had missing data for some of the lenses.</population>
          <units>Degree of rotation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="13"/>
                <count group_id="O4" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" spread="1.6"/>
                    <measurement group_id="O2" value="9.0" spread="6.9"/>
                    <measurement group_id="O3" value="5.9" spread="2.9"/>
                    <measurement group_id="O4" value="9.5" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0080</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-6.0</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>6.8</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus balafilcon A</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0049</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-2.9</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>3.1</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus lotrafilcon B</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0058</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-6.4</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>5.6</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus omafilcon A</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Degree of Lens Rotation in Inferior Gaze.</title>
        <description>Degree of lens rotation while participant is gazing down.</description>
        <time_frame>After each of the four lens insertions</time_frame>
        <population>Only participants who completed the study per protocol. Some participants had missing data for some of the lenses.</population>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A Toric</title>
            <description>senofilcon A toric worn in either the first, second, third or fourth periods.</description>
          </group>
          <group group_id="O2">
            <title>Balafilcon A Toric</title>
            <description>balafilcon A toric worn in either the first, second, third or fourth periods</description>
          </group>
          <group group_id="O3">
            <title>Lotrafilcon B Toric</title>
            <description>lotrafilcon B toric worn in either the first, second, third, or fourth periods.</description>
          </group>
          <group group_id="O4">
            <title>Omafilcon A Toric</title>
            <description>omafilcon A toric worn in either the first, second, third, or fourth periods.</description>
          </group>
        </group_list>
        <measure>
          <title>Degree of Lens Rotation in Inferior Gaze.</title>
          <description>Degree of lens rotation while participant is gazing down.</description>
          <population>Only participants who completed the study per protocol. Some participants had missing data for some of the lenses.</population>
          <units>Degree of rotation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="13"/>
                <count group_id="O4" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" spread="4.3"/>
                    <measurement group_id="O2" value="5.0" spread="4.0"/>
                    <measurement group_id="O3" value="4.2" spread="6.3"/>
                    <measurement group_id="O4" value="2.4" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.27</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-1.2</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>3.7</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus balafilcon A</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.85</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.3</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>6.0</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilocon A minus lotrafilcon B</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.73</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.3</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>2.6</dispersion_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Mean difference is senofilcon A minus omifilcon A</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Lotrafilcon B / Senofilcon A / Balafilcon A / Omafilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="E2">
          <title>Lotrafilcon B / Omafilcon A / Senofilcon A / Balafilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="E3">
          <title>Lotrafilcon B / Balafilcon A / Senofilcon A / Omafilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="E4">
          <title>Senofilcon A / Lotrafilcon B / Omafilcon A / Balafilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="E5">
          <title>Senofilcon A / Omafilcon A / Balafilcon A / Lotrafilcon B</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="E6">
          <title>Senofilcon A / Balafilcon A / Lotrafilcon B / Omafilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="E7">
          <title>Omafilcon A / Lotrafilcon B / Senofilcon A / Balafilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="E8">
          <title>Balafilcon A / Lotrafilcon B / Senofilcon A / Omafilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="E9">
          <title>Balafilcon A / Lotrafilcon B / Omafilcon A / Senofilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="E10">
          <title>Balafilcon A / Senofilcon A / Lotrafilcon B / Omafilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="E11">
          <title>Balafilcon A / Senofilcon A / Omafilcon A / Lotrafilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
        <group group_id="E12">
          <title>Balafilcon A / Omafilcon A / Lotrafilcon B / Senofilcon A</title>
          <description>All lenses were toric lenses. The order of lenses in the title relates to the period of administration.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="1"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="1"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kurt Moody, OD FAAO</name_or_title>
      <organization>Vistakon</organization>
      <phone>904-443-3088</phone>
      <email>kmoody1@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

